These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 25093717)

  • 1. Cystic fibrosis related liver disease--another black box in hepatology.
    Staufer K; Halilbasic E; Trauner M; Kazemi-Shirazi L
    Int J Mol Sci; 2014 Aug; 15(8):13529-49. PubMed ID: 25093717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystic Fibrosis-related Liver Disease: Research Challenges and Future Perspectives.
    Debray D; Narkewicz MR; Bodewes FAJA; Colombo C; Housset C; de Jonge HR; Jonker JW; Kelly DA; Ling SC; Poynard T; Sogni P; Trauner M; Witters P; Baumann U; Wilschanski M; Verkade HJ
    J Pediatr Gastroenterol Nutr; 2017 Oct; 65(4):443-448. PubMed ID: 28753176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Treatment Options for Cystic Fibrosis-Related Liver Disease.
    Staufer K
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic Manifestations of Cystic Fibrosis.
    Sakiani S; Kleiner DE; Heller T; Koh C
    Clin Liver Dis; 2019 May; 23(2):263-277. PubMed ID: 30947876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis, follow-up and treatment of cystic fibrosis-related liver disease.
    van de Peppel IP; Bertolini A; Jonker JW; Bodewes FAJA; Verkade HJ
    Curr Opin Pulm Med; 2017 Nov; 23(6):562-569. PubMed ID: 28837442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver disease in cystic fibrosis.
    Leeuwen L; Fitzgerald DA; Gaskin KJ
    Paediatr Respir Rev; 2014 Mar; 15(1):69-74. PubMed ID: 23769887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver disease in patients with cystic fibrosis.
    Kamal N; Surana P; Koh C
    Curr Opin Gastroenterol; 2018 May; 34(3):146-151. PubMed ID: 29438119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum proteome profiling identifies novel and powerful markers of cystic fibrosis liver disease.
    Rath T; Hage L; Kügler M; Menendez Menendez K; Zachoval R; Naehrlich L; Schulz R; Roderfeld M; Roeb E
    PLoS One; 2013; 8(3):e58955. PubMed ID: 23516586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive methods, including transient elastography, for the detection of liver disease in adults with cystic fibrosis.
    Sadler MD; Crotty P; Fatovich L; Wilson S; Rabin HR; Myers RP
    Can J Gastroenterol Hepatol; 2015 Apr; 29(3):139-44. PubMed ID: 25855877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: epidemiology, pathogenesis and management of liver disease in adults with cystic fibrosis.
    Scott J; Jones AM; Piper Hanley K; Athwal VS
    Aliment Pharmacol Ther; 2022 Feb; 55(4):389-400. PubMed ID: 35048397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis-related liver disease is an independent risk factor for mortality and increased health care resource utilization in hospitalized pediatric patients with cystic fibrosis.
    Thavamani A; Umapathi KK; Kutney K; Sferra TJ; Sankararaman S
    Pediatr Pulmonol; 2022 Jul; 57(7):1717-1725. PubMed ID: 35499220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of liver disease on mortality in cystic fibrosis-A systematic review.
    Sasame A; Stokes D; Bourke B; Connolly L; Fitzpatrick E; Rowland M
    J Cyst Fibros; 2022 Mar; 21(2):202-211. PubMed ID: 34380590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The natural history of cystic fibrosis liver disease a prospective cohort study.
    Rowland M; Drummond J; Connolly L; Daly E; McCormick PA; Bourke B; ;
    J Cyst Fibros; 2023 Nov; 22(6):1054-1061. PubMed ID: 37495468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA Sequencing Identifies a Serum MicroRNA Panel, Which Combined With Aspartate Aminotransferase to Platelet Ratio Index Can Detect and Monitor Liver Disease in Pediatric Cystic Fibrosis.
    Calvopina DA; Chatfield MD; Weis A; Coleman MA; Fernandez-Rojo MA; Noble C; Ramm LE; Leung DH; Lewindon PJ; Ramm GA
    Hepatology; 2018 Dec; 68(6):2301-2316. PubMed ID: 30014495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of transient elastography in the non-invasive evaluation of cystic fibrosis liver disease.
    Kitson MT; Kemp WW; Iser DM; Paul E; Wilson JW; Roberts SK
    Liver Int; 2013 May; 33(5):698-705. PubMed ID: 23432782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and characteristics of cystic fibrosis liver disease: a study highlighting the lack of histological diagnosis.
    Issa Z; Gohy S; Zech F; Baldin P; Delire B; Dahlqvist G
    Clin Res Hepatol Gastroenterol; 2022 Nov; 46(9):101977. PubMed ID: 35772685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult-onset cystic fibrosis liver disease: Diagnosis and characterization of an underappreciated entity.
    Koh C; Sakiani S; Surana P; Zhao X; Eccleston J; Kleiner DE; Herion D; Liang TJ; Hoofnagle JH; Chernick M; Heller T
    Hepatology; 2017 Aug; 66(2):591-601. PubMed ID: 28422310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver disease in adult patients with cystic fibrosis: a frequent and independent prognostic factor associated with death or lung transplantation.
    Chryssostalis A; Hubert D; Coste J; Kanaan R; Burgel PR; Desmazes-Dufeu N; Soubrane O; Dusser D; Sogni P
    J Hepatol; 2011 Dec; 55(6):1377-82. PubMed ID: 21703187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver disease in cystic fibrosis.
    Rowland M; Bourke B
    Curr Opin Pulm Med; 2011 Nov; 17(6):461-6. PubMed ID: 21881510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystic fibrosis liver disease - from diagnosis to risk factors.
    Ciucă IM; Pop L; Tămaş L; Tăban S
    Rom J Morphol Embryol; 2014; 55(1):91-5. PubMed ID: 24715171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.